GIP
ADPT icon

Granite Investment Partners’s Adaptive Biotechnologies ADPT Stock Holding History

Granite Investment Partners’s Portfolio ADPT Stock Details ADPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$16.2M Buy
757,217
+257,156
+51% +$3.94M 0.83% 28
2026
Q1 		$6.94M Buy
+500,061
New +$7.97M 0.43% 86
2025
Q4 		– Sell
-10,070
Closed -$151K – 245
2025
Q3 		$151K Buy
10,070
+64
+0.6% +$780 0.01% 234
2025
Q2 		$117K Sell
10,006
-1,443
-13% -$13.1K 0.01% 241
2025
Q1 		$85.1K Buy
+11,449
New +$88K ﹤0.01% 246

Other funds holding ADPT

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Granite Investment Partners's ADPT Position: Q2 2026 in Review

Granite Investment Partners increased its Adaptive Biotechnologies (ADPT) stake by 51% in Q2 2026, buying an estimated $3.94M and bringing the position to 757,217 shares worth $16.2M. The position accounts for 0.83% of the portfolio, ranked #28.

Granite Investment Partners first reported a position in ADPT in Q1 2025 and has held it in 5 quarters since. 301 funds tracked by Wall St. Rank hold ADPT as of Q2 2026.

  • Granite Investment Partners held 757,217 shares of Adaptive Biotechnologies worth $16.2M as of Q2 2026.
  • Granite Investment Partners bought 257,156 Adaptive Biotechnologies shares in Q2 2026, an estimated $3.94M.
  • Adaptive Biotechnologies made up 0.83% of Granite Investment Partners's portfolio in Q2 2026, its #28 holding.
  • Granite Investment Partners first reported a position in Adaptive Biotechnologies in Q1 2025 and has held it in 5 quarters since.
  • 301 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q2 2026.

Based on Granite Investment Partners's 13F filing for Q2 2026, filed 7 Aug 2026.